What Makes Privia Health (PRVA) One of the Best Mid-Cap Growth Stocks to Invest in

Privia Health Group Inc. (NASDAQ:PRVA) is one of the 8 best mid-cap growth stocks to invest in.

On March 7, J.P. Morgan increased the price target on Privia Health Group Inc. (NASDAQ:PRVA) from $33 to $35. The firm maintained an Overweight rating on the stock that now offers a revised upside potential of more than 57%. The upward revision comes on the back of a solid fourth-quarter financial report.

Evgeny Atamanenko/Shutterstock.com

On March 2, Jailendra Singh from Truist Financial increased the price target on Privia Health Group Inc. (NASDAQ:PRVA) from $31 to $33, resulting in an adjusted upside potential of more than 48% at the current level. The analyst also reiterated his Buy rating on the stock following recent management discussions.

The sequential fall in collections associated with the fee-for-service model was observed due to the relatively greater number of specialist visits than general practitioner visits, along with certain retroactive billing processing issues that occurred in both California and North Texas areas. According to management, an average of the third and fourth quarter performance better reflects the second-half performance period.

Privia Health Group Inc. (NASDAQ:PRVA) is a physician-enablement company that operates in collaboration with healthcare systems and physicians. The company delivers tech-enabled health tools that streamline the workflows for healthcare providers. It also functions as a care organization that enhances the overall value-based care by engaging with patients and leveraging patient quality metrics.

While we acknowledge the risk and potential of PRVA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PRVA and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.